COCH
Income statement / Annual
Last year (2024), Envoy Medical, Inc.'s total revenue was $225,000.00,
a decrease of 28.80% from the previous year.
In 2024, Envoy Medical, Inc.'s net income was -$20.80 M.
See Envoy Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$225,000.00 |
$316,000.00 |
$237,000.00 |
$310,000.00 |
$0.00 |
| Cost of Revenue |
$742,000.00
|
$789,000.00
|
$957,000.00
|
$769,000.00
|
$0.00
|
| Gross Profit |
-$517,000.00
|
-$473,000.00
|
-$720,000.00
|
-$459,000.00
|
$0.00
|
| Gross Profit Ratio |
-2.3
|
-1.5
|
-3.04
|
-1.48
|
0
|
| Research and Development Expenses |
$10.18 M
|
$8.96 M
|
$4.52 M
|
$3.94 M
|
$0.00
|
| General & Administrative Expenses |
$6.83 M
|
$7.28 M
|
$3.47 M
|
$2.47 M
|
$0.00
|
| Selling & Marketing Expenses |
$1.73 M
|
$1.67 M
|
$885,000.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.56 M
|
$8.94 M
|
$3.47 M
|
$2.47 M
|
$701.00
|
| Other Expenses |
$0.00
|
$0.00
|
-$7.22 M
|
-$1.80 M
|
$0.00
|
| Operating Expenses |
$18.74 M
|
$17.90 M
|
$7.99 M
|
$6.41 M
|
$701.00
|
| Cost And Expenses |
$19.48 M
|
$18.69 M
|
$8.94 M
|
$7.18 M
|
$701.00
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$816,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$173,000.00
|
$133,000.00
|
$75,000.00
|
$71,000.00
|
$206,297.00
|
| EBITDA |
-$19.81 M |
-$18.24 M |
-$8.63 M |
-$6.80 M |
-$700.00 |
| EBITDA Ratio |
-88.03
|
-57.72
|
-36.42
|
-21.94
|
0
|
| Operating Income Ratio |
-85.58
|
-58.14
|
-36.73
|
-22.16
|
0
|
| Total Other Income/Expenses Net |
-$1.54 M
|
-$11.54 M
|
-$7.22 M
|
-$1.80 M
|
-$1.00
|
| Income Before Tax |
-$20.80 M
|
-$29.91 M
|
-$15.92 M
|
-$8.68 M
|
-$701.00
|
| Income Before Tax Ratio |
-92.42
|
-94.65
|
-67.19
|
-27.98
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$153,485.00
|
-$165,558.00
|
-$206,297.00
|
| Net Income |
-$20.80 M
|
-$29.91 M
|
-$15.92 M
|
-$8.68 M
|
-$701.00
|
| Net Income Ratio |
-92.42
|
-94.65
|
-67.19
|
-27.98
|
0
|
| EPS |
-0.0007 |
-2.38 |
-1.57 |
-0.85 |
0 |
| EPS Diluted |
-0.72 |
-2.38 |
-1.57 |
-0.85 |
0 |
| Weighted Average Shares Out |
$18.79 B
|
$12.55 M
|
$10.15 M
|
$10.15 M
|
$60.38 M
|
| Weighted Average Shares Out Diluted |
$18.79 M
|
$12.55 M
|
$10.15 M
|
$10.15 M
|
$60.38 M
|
| Link |
|
|
|
|
|
